Workflow
Trailbreaker Resources Announces Increase to Flow-Through Financing from $3m to $3.5m
Thenewswire· 2026-03-03 12:45
March 3, 2026 – TheNewswire - VANCOUVER, BRITISH COLUMBIA - Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) further to its February 26, 2026 news release the Company is pleased to announce that its non-brokered $3 million private placement offering (the “Offering”) has been oversubscribed by $500,000 for a total raise of up to $3.5 million.  The Offering will now consist of the sale of the following securities:a. up to 2,500,000 CMETC flow-through units (“CMETC FT Units”) at a price o ...
ETF Innovation: Preparing for the Unexpected
Etftrends· 2026-03-03 12:41
ETF Innovation: Preparing for the Unexpected | ETF TrendsIf advisors were hoping that 2026's macroeconomic uncertainty would go away soon, recent headlines have likely dashed those aspirations.Worries over the direction of inflation have resurfaced yet again, after the [January PPI report] came in far higher than many were expecting it to. Of course, the PPI report came after [a more modest CPI report] for January. However, the monthslong government shutdown last year raised concerns over the potential accu ...
This Stock Market Selloff's Biggest Fallers All Have One Thing in Common
Barrons· 2026-03-03 12:41
Micron, Sandisk, and Corning were among the S&P 500's worst performers ahead of Tuesday's opening bell. ...
A $10,000 Investment in This S&P 500 ETF 20 Years Ago Is Worth More Than Most Americans Have in Retirement Savings
Yahoo Finance· 2026-03-03 12:41
Group 1: Retirement Savings Overview - The average American has over $148,000 in retirement savings, but this is skewed by higher-balance accounts, with only 30% of defined contribution plan accounts at Vanguard exceeding $100,000 [1] - The median balance of a Vanguard retirement account is $38,176, indicating that half of the accounts have less than this amount, which is considered alarmingly low [2] Group 2: Investment Performance - A $10,000 investment in a Vanguard S&P 500 index fund made 20 years ago would be worth nearly $78,000 today, despite significant market downturns during this period [6] - If an investor had started with a $10,000 investment and added $5,000 annually over 20 years, the total value would exceed $513,000, highlighting the power of consistent investing [7]
Cigna names Brian Evanko as CEO
Reuters· 2026-03-03 12:38
Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Cigna names insider Brian Evanko as CEO Evanko, a nearly 30-year veteran at the health insurer, currently oversees the company's portfolio across Cigna Healthcare and Evernorth Health Services. Sign up here. "Brian is an exceptional leader and the right person to guide the Cigna Group into its next chapter," said Cordani, who would become the executive chair of the board following the transiti ...
Amazon: I Bought The Recent Sell-Off
Seeking Alpha· 2026-03-03 12:37
Amazon ( AMZN ) is one of my favorite businesses ever created and I often remind myself of the famous quote from Jeff Bezos. It essentially meant that in Amazon, they don't think what's going to change inWelcome to Cash Flow Venue, where dividends do the heavy lifting! Blending my financial chops with the timeless wisdom of value investing (and love for steady income), I’ve built a rock-solid pillar in my financial foundation through dividend investing. I believe it’s one of the most accessible paths to ach ...
Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma
Globenewswire· 2026-03-03 12:35
Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion’s strategic shift to advancing clinically proven liquid biopsy tests under new leadership MORRISTOWN, N.J., March 03, 2026 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a precision diagnostics company, today announced that it has in-licensed from Cirna Diagnostics LLC, a novel biomarker assay that detects mutant circulating tumor RNA (ctRNA) t ...
Can Lemonade Stock Get to $100?
Yahoo Finance· 2026-03-03 12:35
Lemonade (NYSE: LMND) has kept investors on their toes during the past few years as it builds its artificial intelligence (AI)-based insurance company. Growth is piping hot, and the company is grabbing market share from the big insurance giants. As of this writing, Lemonade stock trades at about $53 per share, which means it would need to nearly double to reach $100. Let's see the path to get there. Will AI create the world's first trillionaire? Our team just released a report on the one little-known compa ...
Ziff Davis to Sell Connectivity Division to Accenture for $1.2 Billion
WSJ· 2026-03-03 12:35
Ziff Davis has struck a deal to sell its connectivity division to Accenture for $1.2 billion in cash. ...
Don't Panic! Create A Plan To Protect Your Retirement Today
Seeking Alpha· 2026-03-03 12:35
If it bleeds, it leads. That's a common saying in journalism, and it applies to financial journalism as much as it does to your local news channel. On your local news, you'll see theRida Morwa is a former investment and commercial Banker, with over 35 years of experience. He has been advising individual and institutional clients on high-yield investment strategies since 1991. Rida Morwa leads the Investing Group High Dividend Opportunities where he teams up with some of Seeking Alpha's top income investing ...